rs146905706

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_203395.3(IYD):​c.604G>A​(p.Ala202Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00234 in 1,614,052 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0018 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0024 ( 6 hom. )

Consequence

IYD
NM_203395.3 missense

Scores

19

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:2

Conservation

PhyloP100: 0.848

Publications

5 publications found
Variant links:
Genes affected
IYD (HGNC:21071): (iodotyrosine deiodinase) This gene encodes an enzyme that catalyzes the oxidative NADPH-dependent deiodination of mono- and diiodotyrosine, which are the halogenated byproducts of thyroid hormone production. The N-terminus of the protein functions as a membrane anchor. Mutations in this gene cause congenital hypothyroidism due to dyshormonogenesis type 4, which is also referred to as deiodinase deficiency, or iodotyrosine dehalogenase deficiency, or thyroid hormonogenesis type 4. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2009]
IYD Gene-Disease associations (from GenCC):
  • thyroid dyshormonogenesis 4
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • familial thyroid dyshormonogenesis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0043366253).
BP6
Variant 6-150394172-G-A is Benign according to our data. Variant chr6-150394172-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 435539.
BS2
High Homozygotes in GnomAdExome4 at 6 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IYDNM_203395.3 linkc.604G>A p.Ala202Thr missense_variant Exon 4 of 5 ENST00000344419.8 NP_981932.1 Q6PHW0-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IYDENST00000344419.8 linkc.604G>A p.Ala202Thr missense_variant Exon 4 of 5 1 NM_203395.3 ENSP00000343763.4 Q6PHW0-1

Frequencies

GnomAD3 genomes
AF:
0.00183
AC:
278
AN:
152102
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000580
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00170
Gnomad ASJ
AF:
0.00634
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.000660
Gnomad MID
AF:
0.0285
Gnomad NFE
AF:
0.00273
Gnomad OTH
AF:
0.000958
GnomAD2 exomes
AF:
0.00222
AC:
558
AN:
251434
AF XY:
0.00230
show subpopulations
Gnomad AFR exome
AF:
0.000246
Gnomad AMR exome
AF:
0.00173
Gnomad ASJ exome
AF:
0.00546
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000554
Gnomad NFE exome
AF:
0.00359
Gnomad OTH exome
AF:
0.00277
GnomAD4 exome
AF:
0.00240
AC:
3503
AN:
1461832
Hom.:
6
Cov.:
31
AF XY:
0.00238
AC XY:
1728
AN XY:
727226
show subpopulations
African (AFR)
AF:
0.000896
AC:
30
AN:
33478
American (AMR)
AF:
0.00170
AC:
76
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00532
AC:
139
AN:
26134
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39696
South Asian (SAS)
AF:
0.000232
AC:
20
AN:
86258
European-Finnish (FIN)
AF:
0.000880
AC:
47
AN:
53408
Middle Eastern (MID)
AF:
0.0140
AC:
81
AN:
5768
European-Non Finnish (NFE)
AF:
0.00266
AC:
2958
AN:
1111972
Other (OTH)
AF:
0.00250
AC:
151
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
188
377
565
754
942
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
100
200
300
400
500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00180
AC:
274
AN:
152220
Hom.:
0
Cov.:
33
AF XY:
0.00187
AC XY:
139
AN XY:
74418
show subpopulations
African (AFR)
AF:
0.000578
AC:
24
AN:
41516
American (AMR)
AF:
0.00170
AC:
26
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00634
AC:
22
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4822
European-Finnish (FIN)
AF:
0.000660
AC:
7
AN:
10600
Middle Eastern (MID)
AF:
0.0204
AC:
6
AN:
294
European-Non Finnish (NFE)
AF:
0.00273
AC:
186
AN:
68014
Other (OTH)
AF:
0.000948
AC:
2
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
13
25
38
50
63
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00266
Hom.:
2
Bravo
AF:
0.00182
TwinsUK
AF:
0.00270
AC:
10
ALSPAC
AF:
0.00182
AC:
7
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00244
AC:
21
ExAC
AF:
0.00247
AC:
300
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.00294
EpiControl
AF:
0.00320

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:2
Jan 10, 2017
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 18, 2021
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.604G>A (p.A202T) alteration is located in exon 4 (coding exon 4) of the IYD gene. This alteration results from a G to A substitution at nucleotide position 604, causing the alanine (A) at amino acid position 202 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

not provided Uncertain:1Benign:1
Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

IYD-related disorder Benign:1
Feb 11, 2020
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.068
BayesDel_addAF
Benign
-0.52
T
BayesDel_noAF
Benign
-0.52
CADD
Benign
11
DANN
Benign
0.63
DEOGEN2
Benign
0.060
.;T;.;.;T;T
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.057
N
LIST_S2
Benign
0.80
T;T;T;T;T;T
M_CAP
Benign
0.0062
T
MetaRNN
Benign
0.0043
T;T;T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-1.1
N;N;N;.;.;.
PhyloP100
0.85
PrimateAI
Benign
0.27
T
PROVEAN
Benign
0.46
N;N;N;N;N;N
REVEL
Benign
0.050
Sift
Benign
0.65
T;T;T;T;T;T
Sift4G
Benign
0.58
T;T;T;T;T;T
Polyphen
0.0010, 0.0
.;B;B;.;.;.
Vest4
0.12
MVP
0.41
MPC
0.059
ClinPred
0.0017
T
GERP RS
-2.2
Varity_R
0.20
gMVP
0.39
Mutation Taster
=94/6
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs146905706; hg19: chr6-150715308; API